In metastatic melanoma, it has been reported that the majority of tumor-infiltrating lymphocytes (TILs) derived from HLA-A2 positive patients were able to recognize the immunodominant epitope of MART-1, i.e., the fragment of the protein consisting of the amino acids 26–35 (MART-126–35) [8]. Here, MLANA is linked to neoplasm.